Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
07/2012
07/26/2012WO2012097682A1 Bicyclic inhibitors of alk
07/26/2012WO2012097479A1 Bicyclic inhibitors of anaphastic lymphoma kinase
07/26/2012WO2012097478A1 Bicyclic carboxamide inhibitors of kinases
07/26/2012WO2012097427A1 Compounds and compositions for the treatment of cancer
07/26/2012WO2012075492A3 Carbocycle-substituted purine and 7-deazapurine compounds
07/26/2012WO2012075210A3 Method for treating refractory cancer
07/26/2012WO2012066581A9 Novel conjugates for targeted drug delivery
07/26/2012WO2012061012A3 4-amino-2h-pyran-2-one analogs as anticancer agents
07/26/2012WO2012058673A3 Enhanced cancer treatment and monitoring using recombinant vectors
07/26/2012WO2012053862A3 Composition comprising a red garlic extract for preventing or treating diseases caused by respiratory apoptosis
07/26/2012WO2012053787A3 Aryloxy phenoxy acrylic compound having hif-1 inhibition activity, method for preparing same, and pharmaceutical composition containing same as an active ingredient
07/26/2012WO2012051407A3 Molecular containers and methods of making and using same
07/26/2012WO2012050393A3 Novel compound of a reverse-turn mimetic and a production method and use therefor
07/26/2012WO2012048129A3 Inhibitors of polo-like kinase
07/26/2012US20120190975 Nanoparticles for use in tumor diagnosis and therapy
07/26/2012US20120190821 Recombinant soluble fc receptors
07/26/2012US20120190738 Inhibitors of phosphatidylinositol-3-kinase (pi3) and inducers of nitric oxide (no)
07/26/2012US20120190735 Cancer Cell Apoptosis
07/26/2012US20120190732 Multifunctional Aptamer-Nucleic Acid Nanostructures for Tumor-Targeted Killing
07/26/2012US20120190731 Methods and compositions to reduce oxidative stress
07/26/2012US20120190730 Targeting cells with altered microrna expression
07/26/2012US20120190729 Mirna inhibition of six1 expression
07/26/2012US20120190724 Novel anticancer-aiding compound, method for preparing the same, anticancer-aiding composition containing the same and method for reducing anticancer drug resistance using the same
07/26/2012US20120190720 Combination Therapy With Parp Inhibitors
07/26/2012US20120190718 Diarylthiohydantoin compounds
07/26/2012US20120190711 Lenalidomide salts
07/26/2012US20120190710 Bicyclo-heptan-2-amines
07/26/2012US20120190709 Indazolyl-substituted dihydroisoxa-zolopyridines and methods of use thereof
07/26/2012US20120190707 Selective inhibitors of akt and methods of using same
07/26/2012US20120190703 Salts of 13a-(s)desoxytylophorinine, preparation methods and pharmaceutical compositions and uses thereof
07/26/2012US20120190700 Novel 4-amino-n-hydroxy-benzamides for the treatment of cancer
07/26/2012US20120190698 Methods of predicting thiopurine response
07/26/2012US20120190693 Reverse Amide Compounds As Protein Deacetylase Inhibitors And Methods Of Use Thereof
07/26/2012US20120190688 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
07/26/2012US20120190681 Picolinamide inhibitors of kinases
07/26/2012US20120190679 Novel Protein Kinase B Inhibitors - 060
07/26/2012US20120190678 Substituted pyrazolo-quinazoline derivatives as kinase inhibitors
07/26/2012US20120190677 Novel tetrahydroquinoline derivatives
07/26/2012US20120190673 Pyrazole compounds that modulate the activity of cdk, gsk and aurora kinases
07/26/2012US20120190669 Oxindole compounds
07/26/2012US20120190666 Heteroaryl Compounds as PIKK Inhibitors
07/26/2012US20120190665 Pyrazolopyrimidine jak inhibitor compounds and methods
07/26/2012US20120190660 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-diene-11-ethynylphenyl derivatives, methods for the production thereof and use thereof for treating diseases
07/26/2012US20120190654 Novel bicyclic urea compounds
07/26/2012US20120190651 Anti-inflammatory compounds
07/26/2012US20120190649 Bicyclic aryl sphingosine 1-phosphate analogs
07/26/2012US20120190646 Compositions Comprising Thalidomide and Artemisinin for the Treatment of Cancer
07/26/2012US20120190639 Treatment or prophylaxis of proliferative conditions
07/26/2012US20120190638 Methods of treating hematologic cancers
07/26/2012US20120190634 Lipoteichoic acid-derived glycolipids, and compositions comprising same
07/26/2012US20120190633 Monophosphorylated lipid a derivatives
07/26/2012US20120190632 Anti-bacterial infection, inflammation, and leukemia composition and use thereof
07/26/2012US20120190628 Genes and polypeptides relating to human colon cancers
07/26/2012US20120190625 Novel peptide and use thereof
07/26/2012US20120190622 Inhibitors of the epidermal growth factor receptor-heat shock protein 90 binding interaction
07/26/2012US20120190612 Methods of treatment
07/26/2012US20120189718 Medicine for dissolving and eliminating wart and excrescence consisting of protein and its uses
07/26/2012US20120189717 Method of using beta-hydroxy-beta-methylbutyrate and fatty acids for treating disease-associated wasting
07/26/2012US20120189716 Method of using beta-hydroxy-beta-methylbutyrate for treating disease-associated wasting
07/26/2012US20120189715 Compositions including beta-hydroxy-beta-methylbutyrate and uses thereof
07/26/2012US20120189714 Compositions including beta-hydroxy-beta-methylbutyrate
07/26/2012US20120189713 Monomers and phase-separated biocompatible polymer compositions prepared therefrom for medical uses
07/26/2012US20120189701 Combination therapy with thiocolchicine derivatives
07/26/2012US20120189700 Nanoparticle Based Immunological Stimulation
07/26/2012US20120189694 Co-precipitate comprising a phosphodiesterase-5 inhibitor (pde-5-inhibitor) and a pharmaceutically compatible carrier, production and use thereof
07/26/2012US20120189693 Oral dosage forms
07/26/2012US20120189691 Drug carrier and drug carrier kit for inhibiting fibrosis
07/26/2012US20120189690 Liposomes covered with the Extracellular Domain of the APO2L/Trail Protein
07/26/2012US20120189689 Acoustically sensitive drug delivery particles comprising non-lamellar forming phosphatidylcholine
07/26/2012US20120189688 Carrier component and fabrication method thereof
07/26/2012US20120189670 Pharmaceutical compositions and formulations including inhibitors of the pleckstrin homology domain and methods for using same
07/26/2012US20120189664 Cancer stem cell antigen vaccines and methods
07/26/2012US20120189663 Method of producing a medical composition
07/26/2012US20120189662 Identification of virulence associated regions RD1 and RD5 leading to improve vaccine of M. bovis BCG and M. microti
07/26/2012US20120189646 Novel compounds
07/26/2012US20120189645 Compositions and methods to treat and control tumors
07/26/2012US20120189644 Anti-mesothelin immunoconjugates and uses therefor
07/26/2012US20120189641 Combination anti-cancer therapy
07/26/2012US20120189636 Human serum amyloid-a3 antibody and use thereof
07/26/2012US20120189634 Taci as an anti-tumor agent
07/26/2012US20120189633 Anti-kit antibodies and uses thereof
07/26/2012US20120189630 BISPECIFIC EGFRvIII ANTIBODY ENGAGING MOLECULES
07/26/2012US20120189625 Compositions and Methods for Treating Hematological Cancers Targeting the SIRPA CD47 Interaction
07/26/2012US20120189624 Treatment and prophylaxis of amyloidosis
07/26/2012US20120189623 Cyclized derivatives as eg-5 inhibitors
07/26/2012US20120189622 Anti-cd38 human antibodies and uses thereof
07/26/2012US20120189620 Methods for treating non-functioning pituitary adenoma
07/26/2012US20120189618 Superior efficacy of cd37 antibodies in cll blood samples
07/26/2012US20120189615 CROSS-ß STRUCTURE COMPRISING AMYLOID-BINDING PROTEINS AND METHODS FOR DETECTION OF THE CROSS-ß STRUCTURE, FOR MODULATING CROSS-ß STRUCTURES FIBER FORMATION AND FOR MODULATING CROSS-ß STRUCTURE-MEDIATED TOXICITY
07/26/2012US20120189614 Inhibitors of filovirus entry into host cells
07/26/2012US20120189612 Compositions and methods for treating cancer while preventing or reducing cardiotoxicity and/or cardiomyopathy
07/26/2012US20120189594 Methods for promoting hsc self-renewal
07/26/2012US20120189593 Methods for promoting hsc engraftment
07/26/2012US20120189592 Methods for promoting hematopoietic reconstitution
07/26/2012US20120189583 Placental or umbilical cord tissue compositions
07/26/2012US20120189574 Methods for hematopoietic precursor mobilization
07/26/2012US20120189573 Methods of using death receptor agonists and EGFR inhibitors
07/26/2012US20120189572 Vaccines targeting cellular death receptors
07/26/2012US20120189571 Nanoscale platinum compounds and methods of use thereof
07/26/2012US20120189563 Oral composition for alleviating ultraviolet irradiation-induced damage
1 ... 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 ... 2211